Kevin J. Gilligan, Ph.D. is a virologist and emerging disease expert with over 30 years of experience in academia, government and industry developing vaccines, drugs and diagnostics to address public health issues related to global emerging disease.  Dr. Gilligan recently left HHS/BARDA (U.S. Department of Health and Human Services/Biomedical Advanced Research and Development Authority), where he focused on developing drugs and diagnostics for pandemic influenza, to join ClinicalRM as Senior Scientific Advisor.